ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,775,765 | -20.6% | 934,583 | -10.2% | 0.01% | -22.2% |
| Q2 2023 | $21,131,154 | +13.8% | 1,040,431 | +2.2% | 0.01% | +12.5% |
| Q1 2023 | $18,567,025 | +1.4% | 1,017,929 | +15.0% | 0.01% | 0.0% |
| Q4 2022 | $18,304,509 | -32.5% | 885,131 | -14.6% | 0.01% | -38.5% |
| Q3 2022 | $27,117,000 | -5.2% | 1,036,597 | -8.1% | 0.01% | 0.0% |
| Q2 2022 | $28,596,000 | -15.3% | 1,128,498 | +5.5% | 0.01% | 0.0% |
| Q1 2022 | $33,767,000 | +1783.3% | 1,069,943 | +2315.2% | 0.01% | +1200.0% |
| Q4 2021 | $1,793,000 | -0.2% | 44,300 | -14.0% | 0.00% | 0.0% |
| Q3 2021 | $1,796,000 | +27.0% | 51,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,414,000 | +11.9% | 51,500 | +14.4% | 0.00% | 0.0% |
| Q1 2021 | $1,264,000 | +10.9% | 45,000 | +2.5% | 0.00% | 0.0% |
| Q4 2020 | $1,140,000 | +51.6% | 43,900 | 0.0% | 0.00% | – |
| Q3 2020 | $752,000 | -39.8% | 43,900 | -13.1% | 0.00% | -100.0% |
| Q2 2020 | $1,249,000 | +132.6% | 50,500 | +30.5% | 0.00% | – |
| Q1 2020 | $537,000 | +73.8% | 38,700 | +26.5% | 0.00% | – |
| Q4 2019 | $309,000 | +22.6% | 30,600 | +10.5% | 0.00% | – |
| Q3 2019 | $252,000 | +12.0% | 27,700 | -2.1% | 0.00% | – |
| Q2 2019 | $225,000 | -17.0% | 28,300 | +30.4% | 0.00% | – |
| Q1 2019 | $271,000 | +133.6% | 21,700 | +100.9% | 0.00% | – |
| Q4 2018 | $116,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |